国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
上市药品生脉饮健康志愿者临床耐受性再评价
Clinical Reevaluate of the Tolerance of Marketed Drug-Shengmai Drink
  
DOI:
中文关键词:  生脉饮 健康志愿者 临床耐受性 人参 麦冬 五味子 心电图 实验室检查 安全性 心血管疾病
英文关键词:Shengmai drink,Normal volunteers,Tolerance,Drug reevaluate
基金项目:
李艳红  徐戎  龚培力  曾繁典
华中科技大学同济医学院临床药理研究所 武汉430030 (李艳红,徐戎,龚培力)
,华中科技大学同济医学院临床药理研究所 武汉430030(曾繁典)
摘要点击次数: 1315
全文下载次数: 89
中文摘要:
      目的:评价健康志愿者单次口服生脉饮的安全性和耐受性。方法:健康成人志愿受试者36例,随机分为4组,分别单次口服生脉饮100、150、200和300mL,观察受试者对生脉饮的耐受性。结果:生脉饮300mL组受试者DBP下降显著,其余生命体征、实验室检查及心电图变化各组均在正常范围。不良反应仅发生在200mL及300mL组,主要症状为轻度头晕,能耐受,无须药物处理可自行消失。结论:36例健康受试者单次口服生脉饮,仅300mL组DBP下降,大剂量组(200—300mL)见少数一过性头晕等轻微不良反应。在常规治疗剂量(100—150mL)范围内,耐受性良好,未见不良反应发生。
英文摘要:
      Objective: To evaluate the safety and tolerability of shengmai drink in healthy volunteers.Method: 36 healthy volunteers were randomly divided into four groups to receive a single oral dose of 100, 150, 200 and 300ml of shengmai drink respectively. The changes of vital signs and laboratory data were recorded.Result: 300ml shengmai drink caused an obvious decrease of diastolic blood pressure. Their records of the cardiovascular system, liver and renal functions were in normal range. The volunteers at a high dose of 200 ml and 300 ml complained of some slight snuffle, which would disappear without any disposal.Conclusion: The results suggested that 300ml shengmai drink caused decrease of diastolic blood pressure and only a large dose of 200 ml and 300 ml led to some slight reversible snuffle. In a routine dose of 100 ml and 150 ml, no adverse effects had been observed.
查看全文  查看/发表评论  下载PDF阅读器
关闭